logo
Infant with rare genetic disorder gets life saving treatment

Infant with rare genetic disorder gets life saving treatment

Time of India2 days ago

Vadodara: An infant boy from Panchmahal district got a new lease of life after he was diagnosed with an extremely rare hormonal disorder. The child was suffering from Aldosterone Synthase Deficiency (ASD), specifically the Corticosterone Methyl Oxidase Type II (CMO II), which slows down growth.
The baby was presented with symptoms of poor feeding, frequent vomiting and developmental delays when it was five months old. The weight of the baby was 5kg and was not increasing. After observing the baby for some time, the doctors advised the parents to get genetic testing done.
The report came in when the boy was seven months old and revealed that he had ASD. The condition affects the body's ability to retain salt and maintain normal blood pressure.
Dr Bhargav Patel, a paediatrician at MT Mirani Hospital, which is run by the Sad Vichar Parivar in Godhra, said tests initially showed electrolyte imbalance and low aldosterone levels, prompting further genetic testing. He added that the condition, caused by mutations in the CYP11B2 gene, is so rare that only a handful of cases have been reported worldwide.
"In this infant, the Thr185Ile mutation was identified. It is the first such case reported not only in Gujarat but across India, marking a rare genetic discovery," said Patel. He added that the diagnosis was confirmed through Whole Exome Sequencing. Treatment was initiated with fludrocortisone and salt supplementation, which led to visible improvements in just a few weeks. The child will have to keep taking hormones orally for life.
"His feeding improved, weight increased and developmental milestones that had stalled began progressing again," said Dr Patel. He emphasized the need for awareness and genetic testing for rare paediatric disorders.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mirrorlights: Autistic patients at high risk of Parkinson's disease: Study
Mirrorlights: Autistic patients at high risk of Parkinson's disease: Study

Time of India

time9 hours ago

  • Time of India

Mirrorlights: Autistic patients at high risk of Parkinson's disease: Study

autism spectrum disorder People with autism could be at a higher risk of developing Parkinson's disease early in life, according to a large-scale study that showed similar underlying biological mechanisms of the from the Karolinska Institutet questioned a possible connection between the neuropsychiatric diagnosis of(ASD), which affects an individual's thought processes, behaviour, and interpersonal communication, and early-onset Parkinson's disease -- a condition that affects locomotion and results, published in JAMA Neurology, show that people with an autism diagnosis were four times more likely to develop Parkinson's disease than people without such a diagnosis.'This indicates that there can be shared biological drivers behind ASD and Parkinson's disease,' said Weiyao Yin, researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.'One hypothesis is that the brain's dopamine system is affected in both cases, since the neurotransmitter dopamine plays an important part in social behavior and motion control,' Yin study is based on registry data from over two million people born in Sweden between 1974 and 1999, who were followed from the ageof 20 up to the end of is well-known that dopamine-producing neurons are degraded in Parkinson's studies have also shown that dopamine is possibly implicated in autism, but more research needs to be done to confirm this.'We hope that our results will eventually help to bring greater clarity to the underlying causes of both ASD and Parkinson's disease,' Yin for more studies, the researchers urged healthcare services to keep people with ASD -- a vulnerable group with high co-morbidity and high use of psychotropics -- under long-term observation.

Infant with rare genetic disorder gets life saving treatment
Infant with rare genetic disorder gets life saving treatment

Time of India

time2 days ago

  • Time of India

Infant with rare genetic disorder gets life saving treatment

Vadodara: An infant boy from Panchmahal district got a new lease of life after he was diagnosed with an extremely rare hormonal disorder. The child was suffering from Aldosterone Synthase Deficiency (ASD), specifically the Corticosterone Methyl Oxidase Type II (CMO II), which slows down growth. The baby was presented with symptoms of poor feeding, frequent vomiting and developmental delays when it was five months old. The weight of the baby was 5kg and was not increasing. After observing the baby for some time, the doctors advised the parents to get genetic testing done. The report came in when the boy was seven months old and revealed that he had ASD. The condition affects the body's ability to retain salt and maintain normal blood pressure. Dr Bhargav Patel, a paediatrician at MT Mirani Hospital, which is run by the Sad Vichar Parivar in Godhra, said tests initially showed electrolyte imbalance and low aldosterone levels, prompting further genetic testing. He added that the condition, caused by mutations in the CYP11B2 gene, is so rare that only a handful of cases have been reported worldwide. "In this infant, the Thr185Ile mutation was identified. It is the first such case reported not only in Gujarat but across India, marking a rare genetic discovery," said Patel. He added that the diagnosis was confirmed through Whole Exome Sequencing. Treatment was initiated with fludrocortisone and salt supplementation, which led to visible improvements in just a few weeks. The child will have to keep taking hormones orally for life. "His feeding improved, weight increased and developmental milestones that had stalled began progressing again," said Dr Patel. He emphasized the need for awareness and genetic testing for rare paediatric disorders.

Parkinson's disease four times more likely among people with autism, study suggests
Parkinson's disease four times more likely among people with autism, study suggests

Time of India

time2 days ago

  • Time of India

Parkinson's disease four times more likely among people with autism, study suggests

New Delhi: People with autism could be four times more likely to develop Parkinson's disease later in life, according to a study among Swedish population. Autism is a neuro-developmental disorder affecting thought processes and social behaviour. It is diagnosed in early childhood, while Parkinson's disease is ageing-related neuro-degeneration, in which one experiences tremors in limbs and affected movement. "This indicates that there can be shared biological drivers behind ASD ( autism spectrum disorder ) and Parkinson's disease," first author Weiyao Yin, a researcher at the department of medical epidemiology and biostatistics, Karolinska Institutet, Sweden, said. The study, published in The Journal of the American Medical Association (JAMA) Neurology, analysed data from more than 22 lakh people born in the country between 1974 and 1999, who were followed from the age of 20 up to the end of 2022. Findings "suggest a potential shared etiology between neuro-developmental disorders and PD (Parkinson's disease), warranting increased awareness of long-term neurological conditions in individuals with ASD," the authors wrote. Yin said, "One hypothesis is that the brain's dopamine system is affected in both cases, since the neurotransmitter (brain chemical) dopamine plays an important part in social behaviour and motion control." While there is considerable evidence that dopamine production is affected in Parkinson's disease, the role of dopamine in autism is not yet clear, even though studies have shown that the brain chemical is involved, the researchers said. The researchers also took into account the fact that people diagnosed with autism are commonly prescribed anti-depressants and anti-psychotic drugs, which can cause Parkinson's-like symptoms. The link between autism and Parkinson's disease became less pronounced, "but the risk was still double", the researchers said. "The healthcare services need to keep people with ASD -- a vulnerable group with high co-morbidity and a high use of psychotropics -- under long-term observation," last author Sven Sandin, a statistician and epidemiologist at the department of medical epidemiology and biostatistics, Karolinska Institutet, said. "At the same time, it's important to remember that a Parkinson's diagnosis before the age of 50 is very rare, including for people with autism," Sandin said. The researchers pointed out that they only analysed early-onset Parkinson's disease before the age of 50 and that the average age of participants by the end of the study was 34. The incidence of Parkinson's disease was therefore very low -- 24 cases among 51,954 people with autism (0.05 per cent), and 438 among 22,26,611 people without autism (0.02 per cent). Future studies will need to examine if the elevated risk persists into older age, the team said. Global estimate of autism prevalence is one per cent, while in India, the estimate is 1.5 per cent, according to a 2023 study published in the Indian Journal of Pediatrics.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store